Literature DB >> 26934162

Oral Parenteral Antimicrobial Therapy Administration in a Homeless Population.

Whitney Hernandez1, Connie Price, Bryan Knepper, Margaret McLees, Heather Young.   

Abstract

Outpatient parenteral antimicrobial therapy (OPAT) is increasingly used to treat serious infections. Patients who identify themselves as homeless may receive OPAT less often, and little is known about their treatment outcomes. The purpose of this study was to describe challenges, treatment completion rates, and cost savings of OPAT in homeless patients discharged from a public safety-net hospital.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26934162     DOI: 10.1097/NAN.0000000000000165

Source DB:  PubMed          Journal:  J Infus Nurs        ISSN: 1533-1458


  4 in total

1.  Outpatient Parenteral Antimicrobial Therapy in Vulnerable Populations-- People Who Inject Drugs and the Homeless.

Authors:  Alison Beieler; Amalia Magaret; Yuan Zhou; Anneliese Schleyer; Anna Wald; Shireesha Dhanireddy
Journal:  J Hosp Med       Date:  2019-02       Impact factor: 2.960

2.  Dalbavancin as Secondary Therapy for Serious Staphylococcus aureus Infections in a Vulnerable Patient Population.

Authors:  Chloe Bryson-Cahn; Alison M Beieler; Jeannie D Chan; Robert D Harrington; Shireesha Dhanireddy
Journal:  Open Forum Infect Dis       Date:  2019-01-30       Impact factor: 3.835

Review 3.  Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK.

Authors:  Ann L N Chapman; Sanjay Patel; Carolyne Horner; Helen Green; Achyut Guleri; Sara Hedderwick; Susan Snape; Julie Statham; Elizabeth Wilson; Mark Gilchrist; R Andrew Seaton
Journal:  JAC Antimicrob Resist       Date:  2019-08-26

4.  Evaluating the safety and effectiveness of a nurse-led outpatient virtual IV vancomycin monitoring clinic: a retrospective cohort study.

Authors:  Kate S Grattan; Mohamed Mohamed Ali; Seyed M Hosseini-Moghaddam; Hayley J I Gilmour; Gregory P Crunican; Erica Hua; Kelly A Muhsin; Rochelle Johnstone; Lise C Bondy; Megan K Devlin; Sarah Shalhoub; Sameer Elsayed; Michael S Silverman
Journal:  JAC Antimicrob Resist       Date:  2021-01-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.